Governments across the world, healthcare providers and device manufacturers can now request a free of charge licence to the design and manufacturing files of a [...]
The biotechnology company focused on developing curative gene therapies for chronic systemic diseases has announced the appointment of Julie Krop M.D. as Chief [...]
Congratulations to Professor Bobby Gaspar of the UCL Great Ormond Street Institute of Child Health who has been named the new CEO of global gene therapy spinout [...]
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics Licens [...]
UCLB spinout companies Odin Vision and Echopoint Medical received awards at the 2019 SEHTA MedTech Business Awards on Thursday 6 February, alongside guest speak [...]
Are you developing an innovative piece of technology or research idea, at UCL, that has the potential to benefit society? Perhaps your project could be the key [...]
DiNAQOR AG, a global gene therapy platform company, today announced a research collaboration and exclusive license agreement with UCL to develop novel gene ther [...]
A FVIII gene therapy treatment, developed by world leading gene therapy expert, Professor Amit Nathwani at UCL has shown positive results in treating patients w [...]
BioMarin today announced it has submitted a marketing application to the European Medicines Agency (EMA), for the investigational gene therapy, valoctocogene ro [...]
UCLB, part of UCL Innovation & Enterprise, launches its search for early-stage social ventures to benefit from Proof of Concept funding. The initiative will [...]
